| | | Yep, all the insurers see margin pressure due to higher medical expand ratios. I do figure that those will get accounted for in insurance premiums eventually, but there is a lag to it.
I decided a while ago to sell HUM, but have added to ELV shares, which is one of my larger positions. I have a small aer position in CNC and might add a few more shares, but have not decided yet. I also look at MOH, but don’t know that stock too well. They have been a fast grower though.
Bought a few share of BP a few days ago. I think it had become just too cheap and the operating results are actually decent. The valuation is way lower than aus peers due to their lousy historical results, their moronic CO2 goals and their UK headquarter.
However, when you look at their operating results, the FCF is actually fairly strong and they pay a good and growing dividend while also buying back shares ( they bought back 17% of outstanding shares the last 2 years) and furthermore they are even production. Then they have an activist breathing down their neck.
I figure before too long they will move their headquarter to the US, abandon the climate goals and BP will become US Petroleum and their multiple will go up by 20% just like that. Small position at this point, but it does remind me of Petrobas in many ways. |
|
